Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.6.1.2 (
guanylate cyclase
)
8,497
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Four monoclonal antibodies to rat lung soluble
guanylate cyclase
[GTP pyrophosphate-lyase (cyclizing)
EC 4.6.1.2
] have been produced by fusing spleen cells from immunized BALB/c mice with
SP-2
/0 myeloma cells. The antibodies were detected by their ability to bind immobilized
guanylate cyclase
and by immunoprecipitation of purified enzyme in the presence of second (rabbit anti-mouse) antibody. After subcloning by limiting dilution, hybridomas were injected intraperitoneally into mice to produce ascitic fluid containing 2-5 mg of antibody per ml. The four antibodies obtained had titers of between 1:1580 and 1:3160 but were detectable at dilutions greater than 1:20,000. Soluble
guanylate cyclase
from several rat tissues were crossreactive with the four monoclonal antibodies, suggesting that the soluble enzyme from different rat tissues is antigenically similar. The antibodies also recognized soluble lung enzyme from rat, beef, and pig, while enzyme from rabbit was not crossreactive and mouse enzyme was recognized by only one of the antibodies. Particulate
guanylate cyclase
from a number of tissues had only minimal crossreactivity with the antibodies. Immunoprecipitated
guanylate cyclase
retained catalytic activity, could be activated with sodium nitroprusside, and was inhibited by cystamine. None of the antibodies were inhibitory under the conditions examined. These antibodies will be useful probes for the study of
guanylate cyclase
regulation and function under a variety of physiological conditions.
...
PMID:Production and characterization of monoclonal antibodies to soluble rat lung guanylate cyclase. 611 73